Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5'-nucleotidase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
5'-nucleotidase deficiency
[Hemolytic anemias caused by erythrocyte enzyme disorders]
Acquired Immunodeficiency Syndrome
Are syntax errors due to the amino acid sequence of neuroleukin involved in the pathogenesis of the acquired immunodeficiency syndrome (AIDS) and insulin dependent diabetes mellitus (IDDM)?
Acquired Immunodeficiency Syndrome
Enzyme abnormalities of patients with acquired immunodeficiency syndrome.
Acquired Immunodeficiency Syndrome
Immunohistochemistry of human immunodeficiency virus in the central nervous system and an hypothesis concerning the pathogenesis of AIDS meningoencephalomyelitis.
Acquired Immunodeficiency Syndrome
Laboratory aids to diagnosis--enzymes.
Acquired Immunodeficiency Syndrome
Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons.
Adenocarcinoma
An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1.
Adenocarcinoma
Autocrine motility factor in pulmonary adenocarcinomas: results of an immunohistochemical study.
Adenocarcinoma
Autocrine motility factor receptor expression as a prognostic factor in pulmonary adenocarcinoma.
Adenocarcinoma
Autocrine motility factor receptor expression implies an unfavourable prognosis in resected stage I pulmonary adenocarcinomas.
Adenocarcinoma
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Adenocarcinoma of Lung
Nucleokinesis: distinct pattern of cell translocation in response to an autocrine motility factor-like substance or fibronectin.
adenylate kinase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
adenylate kinase deficiency
Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
Alzheimer Disease
Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic creutzfeldt-jakob disease and the implication of glycolytic enzymes in prion-induced pathology.
Alzheimer Disease
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Alzheimer Disease
Impaired brain glucose metabolism in patients with Down syndrome.
Anemia
Inhibitory effect of mannose on erythrocyte defense against oxidants.
Anemia
Isolation of novel animal cell lines defective in glycerolipid biosynthesis reveals mutations in glucose-6-phosphate isomerase.
Anemia
On the serum activity of lactic acid dehydrogenase and phosphohexose isomerase in pernicious and hemolytic anemias.
Anemia, Diamond-Blackfan
Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
Anemia, Hemolytic
A Novel Mutation of Glucose Phosphate Isomerase (GPI) Causing Severe Neonatal Anemia Due to GPI Deficiency.
Anemia, Hemolytic
Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency.
Anemia, Hemolytic
Congenital haemolytic anaemia resulting from glucose phosphate isomerase deficiency: genetics, clinical picture, and prenatal diagnosis.
Anemia, Hemolytic
Erythrocyte pyruvate kinase- and glucose phosphate isomerase deficiency: perturbation of glycolysis by structural defects and functional alterations of defective enzymes and its relation to the clinical severity of chronic hemolytic anemia.
Anemia, Hemolytic
First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency.
Anemia, Hemolytic
Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: a new variant (type Nordhorn). I. Clinical and genetic studies.
Anemia, Hemolytic
Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: a new variant (type Nordhorn). II. Purification and biochemical properties of the defective enzyme.
Anemia, Hemolytic
Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: clinical and familial studies.
Anemia, Hemolytic
Glucose phosphate isomerase deficiency with hereditary nonspherocytic hemolytic anemia.
Anemia, Hemolytic
Glucose phosphate isomerase deficiency: biochemical and molecular genetic studies on the enzyme variants of two patients with severe haemolytic anaemia.
Anemia, Hemolytic
Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation.
Anemia, Hemolytic
Glucose Phosphate Isomerase Deficiency: High Prevalence of p.Arg347His Mutation in Indian Population Associated with Severe Hereditary Non-Spherocytic Hemolytic Anemia Coupled with Neurological Dysfunction.
Anemia, Hemolytic
Glucose-6-phosphate isomerase deficiency associated with nonspherocytic hemolytic anemia in the mouse: an animal model for the human disease.
Anemia, Hemolytic
Glucose-6-phosphate isomerase deficiency-Nahariya: extreme in vitro and in vivo lability of the mutant enzyme.
Anemia, Hemolytic
Glucose-6-phosphate isomerase deficiency.
Anemia, Hemolytic
Hereditary non-spherocytic hemolytic anemia and severe glucose phosphate isomerase deficiency in an Indian patient homozygous for the L487F mutation in the human GPI gene.
Anemia, Hemolytic
Hereditary nonspherocytic hemolytic anemia caused by red cell glucose-6-phosphate isomerase (GPI) deficiency in two Portuguese patients: Clinical features and molecular study.
Anemia, Hemolytic
Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia.
Anemia, Hemolytic
Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency.
Anemia, Hemolytic
Molecular diagnosis of unexplained haemolytic anaemia using targeted next-generation sequencing panel revealed (p.Ala337Thr) novel mutation in GPI gene in two Indian patients.
Anemia, Hemolytic
Red cell glucose phosphate isomerase (GPI): a molecular study of three novel mutations associated with hereditary nonspherocytic hemolytic anemia.
Anemia, Hemolytic
Study of the molecular defects in glucose phosphate isomerase-deficient patients affected by chronic hemolytic anemia.
Anemia, Hemolytic
Successful long-term phenobarbital therapy of hyperbilirubinemia in congenital hemolytic anemia due to glucose phosphate isomerase deficiency.
Anemia, Hemolytic
The characterization of gene mutations for human glucose phosphate isomerase deficiency associated with chronic hemolytic anemia.
Anemia, Hemolytic
The crystal structure of human phosphoglucose isomerase at 1.6 A resolution: implications for catalytic mechanism, cytokine activity and haemolytic anaemia.
Anemia, Hemolytic
Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin.
Anemia, Hemolytic
[A case of congenital nonspherocytic hemolytic anemia associated with defective glucose phosphate isomerase]
Anemia, Hemolytic
[Deficit of glucose phosphate isomerase in erythrocytes of a Polish girl with inherited hemolytic anemia]
Anemia, Hemolytic
[Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia]
Anemia, Hemolytic
[Glucose phosphate isomerase type Recklinghausen: a new enzyme variant with haemolytic anaemia (author's transl)]
Anemia, Hemolytic, Congenital
Congenital Hemolytic Anemia Because of Glucose Phosphate Isomerase Deficiency: Identification of 2 Novel Missense Mutations in the GPI Gene.
Anemia, Hemolytic, Congenital
Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: clinical and familial studies.
Anemia, Hemolytic, Congenital
Hemodialysis and kidney transplantation in a patient with glucose phosphate isomerase deficiency.
Anemia, Hemolytic, Congenital
Inhibitory effect of mannose on erythrocyte defense against oxidants.
Anemia, Hemolytic, Congenital
Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia.
Anemia, Hemolytic, Congenital
Successful long-term phenobarbital therapy of hyperbilirubinemia in congenital hemolytic anemia due to glucose phosphate isomerase deficiency.
Anemia, Hemolytic, Congenital Nonspherocytic
Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: a new variant (type Nordhorn). I. Clinical and genetic studies.
Anemia, Hemolytic, Congenital Nonspherocytic
Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: a new variant (type Nordhorn). II. Purification and biochemical properties of the defective enzyme.
Anemia, Hemolytic, Congenital Nonspherocytic
[A case of congenital nonspherocytic hemolytic anemia associated with defective glucose phosphate isomerase]
Anemia, Hemolytic, Congenital Nonspherocytic
[Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia]
Anemia, Neonatal
A Novel Mutation of Glucose Phosphate Isomerase (GPI) Causing Severe Neonatal Anemia Due to GPI Deficiency.
Anemia, Refractory
Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases.
Anemia, Sickle Cell
Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
Arthritis
18?F-Fluoride positron emission tomography/computed tomography for noninvasive in vivo quantification of pathophysiological bone metabolism in experimental murine arthritis.
Arthritis
A Glucose-6-Phosphate Isomerase Peptide Induces T and B Cell-Dependent Chronic Arthritis in C57BL/10 Mice: Arthritis without Reactive Oxygen Species and Complement.
Arthritis
A mouse herpesvirus induces relapse of experimental autoimmune arthritis by infection of the inflammatory target tissue.
Arthritis
A new model for rheumatoid arthritis?
Arthritis
A novel antagonist of the prostaglandin E(2) EP(4) receptor inhibits Th1 differentiation and Th17 expansion and is orally active in arthritis models.
Arthritis
A Semi-Physiologically Based Pharmacokinetic Model Describing the Altered Metabolism of Midazolam Due to Inflammation in Mice.
Arthritis
Activation of Invariant NKT cells with glycolipid ligand ?-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
Arthritis
Adenosine 2a receptor signals block autoimmune arthritis by inhibiting pathogenic germinal center T follicular helper cells.
Arthritis
Altered peptide ligands inhibit arthritis induced by glucose-6-phosphate isomerase peptide.
Arthritis
Ameliorated course of glucose-6-phosphate isomerase (G6PI)-induced arthritis in IFN-? receptor knockout mice exposes an arthritis-promoting role of IFN-?.
Arthritis
Antigen-specific over-expression of human cartilage glycoprotein 39 on CD4+ CD25+ forkhead box protein 3+ regulatory T cells in the generation of glucose-6-phosphate isomerase-induced arthritis.
Arthritis
Arthritogenic monoclonal antibodies from K/BxN mice.
Arthritis
Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells.
Arthritis
Arthritogenic T cell epitope in glucose-6-phosphate isomerase-induced arthritis.
Arthritis
Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis.
Arthritis
Autoantibodies against glucose-6-phosphate isomerase are not a diagnostic marker for juvenile idiopathic arthritis.
Arthritis
Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target.
Arthritis
Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease.
Arthritis
CD4(+)CD25(+) Regulatory T Cells Selectively Diminish Systemic Autoreactivity in Arthritic K/BxN Mice.
Arthritis
Characterization of an Expanded IL-10-Producing-Suppressive T Cell Population Associated with Immune Tolerance.
Arthritis
Combination treatment with fingolimod and a pathogenic antigen prevents relapse of glucose-6-phosphate isomerase peptide-induced arthritis.
Arthritis
Comparative suppressive effects of tyrosine kinase inhibitors imatinib and nilotinib in models of autoimmune arthritis.
Arthritis
Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase.
Arthritis
Crucial role of TNF?-induced adipose-related protein (TIARP) in the pathogenesis of autoimmune arthritis.
Arthritis
Diagnostic and prognostic values of anti glucose-6-phosphate isomerase antibodies in community-recruited patients with very early arthritis.
Arthritis
Efficacy of Combination Treatment with Fingolimod (FTY720) plus Pathogenic Autoantigen in a Glucose-6-phosphate Isomerase Peptide (GPI325-339)-induced Arthritis Mouse Model.
Arthritis
Evaluation of the therapeutic potential of the selective p38 MAPK inhibitor Skepinone-L and the dual p38/JNK 3 inhibitor LN 950 in experimental K/BxN serum transfer arthritis.
Arthritis
Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Model.
Arthritis
Glucose-6-phosphate isomerase variants play a key role in the generation of anti-GPI antibodies: possible mechanism of autoantibody production.
Arthritis
Heterogeneous stock mice are susceptible to encephalomyelitis and antibody-initiated arthritis but not to collagen- and G6PI-induced arthritis.
Arthritis
How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease.
Arthritis
Hypoxia-induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis.
Arthritis
Immunization with an immunodominant self-peptide derived from glucose-6-phosphate isomerase induces arthritis in DBA/1 mice.
Arthritis
Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice.
Arthritis
In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.
Arthritis
In vivo molecular imaging of experimental joint inflammation by combined 18F-FDG positron emission tomography and computed tomography.
Arthritis
Incidence and severity of G6PI-induced arthritis are not increased in genetically distinct mouse strains upon aging.
Arthritis
Inducible costimulator (ICOS) blockade inhibits accumulation of polyfunctional T helper 1/T helper 17 cells and mitigates autoimmune arthritis.
Arthritis
Induction of a B-cell-dependent chronic arthritis with glucose-6-phosphate isomerase.
Arthritis
Inhibition of Glycolysis Reduces Disease Severity in an Autoimmune Model of Rheumatoid Arthritis.
Arthritis
Interleukin-4 can be a key positive regulator of inflammatory arthritis.
Arthritis
Interleukin-6 regulates anti-arthritic effect of methotrexate via reduction of SLC19A1 expression in a mouse arthritis model.
Arthritis
Lessons from animal models of arthritis.
Arthritis
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.
Arthritis
Mechanism of Immunoregulatory Properties of Vasoactive Intestinal Peptide in the K/BxN Mice Model of Autoimmune Arthritis.
Arthritis
Optimized protein kinase C? (PKC?) inhibitors reveal only modest anti-inflammatory efficacy in a rodent model of arthritis.
Arthritis
Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
Arthritis
Quantification of arthritic bone degradation by analysis of 3D micro-computed tomography data.
Arthritis
Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4.
Arthritis
Regulatory T cells control the transition from acute into chronic inflammation in glucose-6-phosphate isomerase-induced arthritis.
Arthritis
Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes.
Arthritis
Targeted mast cell silencing protects against joint destruction and angiogenesis in experimental arthritis in mice.
Arthritis
The contribution of inflammation and bone destruction to pain in arthritis - a study in murine glucose-6-phosphate isomerase (G6PI)-induced arthritis.
Arthritis
The effect of gabapentin and ketorolac on allodynia and conditioned place preference in antibody-induced inflammation.
Arthritis
The K/BxN arthritis model.
Arthritis
The K/BxN mouse model of inflammatory arthritis: theory and practice.
Arthritis
The role and clinical implications of G6PI in experimental models of rheumatoid arthritis.
Arthritis
The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis.
Arthritis
The role of FcgammaR signaling in the K/B x N serum transfer model of arthritis.
Arthritis
Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis.
Arthritis
Tumor necrosis factor alpha-induced adipose-related protein expression in experimental arthritis and in rheumatoid arthritis.
Arthritis
[Animal models for bone and joint disease. K/BxN mice - serum transferred arthritis -].
Arthritis, Experimental
Heterogeneous stock mice are susceptible to encephalomyelitis and antibody-initiated arthritis but not to collagen- and G6PI-induced arthritis.
Arthritis, Juvenile
Autoantibodies against glucose-6-phosphate isomerase are not a diagnostic marker for juvenile idiopathic arthritis.
Arthritis, Juvenile
Autoantibodies in juvenile idiopathic arthritis: glucose-6-phosphate isomerase is not a specific target.
Arthritis, Rheumatoid
Acid-induced conformational changes in phosphoglucose isomerase result in its increased cell surface association and deposition on fibronectin fibrils.
Arthritis, Rheumatoid
Activation of Invariant NKT cells with glycolipid ligand ?-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis.
Arthritis, Rheumatoid
Anti-citrullinated glucose-6-phosphate isomerase peptide antibodies in patients with rheumatoid arthritis are associated with HLA-DRB1 shared epitope alleles and disease activity.
Arthritis, Rheumatoid
Anti-glucose-6-phosphate isomerase, anti-cyclic citrullinated peptide antibodies and HLA-DRB1 genotypes in Japanese patients with early rheumatoid arthritis.
Arthritis, Rheumatoid
Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis.
Arthritis, Rheumatoid
Association of autoantibodies to glucose-6-phosphate isomerase with extraarticular complications in rheumatoid arthritis.
Arthritis, Rheumatoid
Autoantibodies to glucose-6-phosphate isomerase are elevated in the synovial fluid of rheumatoid arthritis patients.
Arthritis, Rheumatoid
Autoantibodies to GPI in rheumatoid arthritis: linkage between an animal model and human disease.
Arthritis, Rheumatoid
Characterisation of Th1/Th2 type, glucose-6-phosphate isomerase reactive T cells in the generation of rheumatoid arthritis.
Arthritis, Rheumatoid
Detection of antibodies against glucose 6-phosphate isomerase in synovial fluid of rheumatoid arthritis using surface plasmon resonance (BIAcore).
Arthritis, Rheumatoid
Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis.
Arthritis, Rheumatoid
Differential MHC Class II Presentation of a Pathogenic Autoantigen during Health and Disease.
Arthritis, Rheumatoid
Dynamic visualization of a joint-specific autoimmune response through positron emission tomography.
Arthritis, Rheumatoid
Efficacy of Combination Treatment with Fingolimod (FTY720) plus Pathogenic Autoantigen in a Glucose-6-phosphate Isomerase Peptide (GPI325-339)-induced Arthritis Mouse Model.
Arthritis, Rheumatoid
Elevated Serum Glucose-6-Phosphate Isomerase Correlates with Histological Disease Activity and Clinical Improvement After Initiation of Therapy in Patients with Rheumatoid Arthritis.
Arthritis, Rheumatoid
Expression of autocrine motility-like factor in rheumatoid synovial fluid.
Arthritis, Rheumatoid
Glucose-6-Phosphate Isomerase (G6PI) Mediates Hypoxia-Induced Angiogenesis in Rheumatoid Arthritis.
Arthritis, Rheumatoid
Glucose-6-phosphate isomerase is associated with disease activity and declines in response to infliximab treatment in rheumatoid arthritis.
Arthritis, Rheumatoid
Glucose-6-phosphate isomerase is not a specific autoantigen in rheumatoid arthritis.
Arthritis, Rheumatoid
Glucose-6-phosphate isomerase promotes the proliferation and inhibits the apoptosis in fibroblast-like synoviocytes in rheumatoid arthritis.
Arthritis, Rheumatoid
High affinity glycosaminoglycan and autoantigen interaction explains joint specificity in a mouse model of rheumatoid arthritis.
Arthritis, Rheumatoid
Hypoxia-induced upregulation of the glycolytic enzyme glucose-6-phosphate isomerase perpetuates rheumatoid arthritis.
Arthritis, Rheumatoid
Insufficient autoantigen presentation and failure of tolerance in a mouse model of rheumatoid arthritis.
Arthritis, Rheumatoid
Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders.
Arthritis, Rheumatoid
Revisit of autoimmunity to glucose-6-phosphate isomerase in experimental and rheumatoid arthritis.
Arthritis, Rheumatoid
Value of serum glucose-6-phosphate isomerase in patients with rheumatoid arthritis and correlation with disease activity: A case-control study.
Arthritis, Rheumatoid
[Diagnostic value of glucose-6-phosphate isomerase in rheumatoid arthritis patients: systematic review]
Arthritis, Rheumatoid
[Significance of antibodies to the citrullinated glucose-6-phosphate isomerase peptides in rheumatoid arthritis].
Arthritis, Rheumatoid
[Significance of glucose-6-phosphate isomerase assay in early diagnosis of rheumatoid arthritis].
Asthenozoospermia
Proteomics analysis of asthenozoospermia and identification of glucose-6-phosphate isomerase as an important enzyme for sperm motility.
Astrocytoma
Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Bone Resorption
Autoantibodies, metalloproteinases and bone markers in rheumatoid arthritis patients are unable to predict their responses to infliximab.
Brain Injuries
Angiogenesis dysregulation in term asphyxiated newborns treated with hypothermia.
Breast Diseases
Clinical significance of serum spermine in breast cancer.
Breast Neoplasms
Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
Breast Neoplasms
Autocrine Motility Factor Modulates EGF-Mediated Invasion Signaling.
Breast Neoplasms
Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells.
Breast Neoplasms
Biochemical studies in breast carcinoma. 1. Serum phosphohexose isomerase, lactate dehydrogenase and its isoenzyme changes.
Breast Neoplasms
Clinical significance of serum spermine in breast cancer.
Breast Neoplasms
Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
Breast Neoplasms
Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer.
Breast Neoplasms
Insulin-like growth factor binding protein-3 interacts with autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and inhibits the AMF/PGI function.
Breast Neoplasms
Integrin alpha6beta4 promotes expression of autotaxin/ENPP2 autocrine motility factor in breast carcinoma cells.
Breast Neoplasms
Metabolic changes in breast carcinoma. II. Phosphohexose isomerase and lactic dehydrogenase levels in serum.
Breast Neoplasms
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Breast Neoplasms
Phosphoglucose Isomerase/Autocrine Motility Factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Breast Neoplasms
Raft-dependent endocytosis of autocrine motility factor is phosphatidylinositol 3-kinase-dependent in breast carcinoma cells.
Breast Neoplasms
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Breast Neoplasms
Serum tumor markers in metastatic breast cancer and course of disease.
Breast Neoplasms
Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis.
Breast Neoplasms
Simultaneous microscopic and biochemical findings in breast carcinoma. Preliminary results.
Breast Neoplasms
Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells.
Breast Neoplasms
The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease.
Breast Neoplasms
The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.
Breast Neoplasms
THE VALUE OF SERUM PHOSPHOHEXOSE ISOMERASE AS AN INDEX OF METASTATIC BREAST CARCINOMA ACTIVITY.
Breast Neoplasms
[Prognostic significance of serum phosphohexose isomerase in metastatic breast cancer]
Breast Neoplasms
[The determination of phosphohexose isomerase in patients with cancer of breast and uterus. A comparison with other tests (author's transl)]
Carcinogenesis
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Carcinogenesis
Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Carcinoma
A trial of phosphohexose isomerase as a means of detecting cervical carcinoma.
Carcinoma
Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Carcinoma
Activities of phosphohexose isomerase and other glycolytic enzymes in normal and tumor tissue of patients with neoplastic diseases: comparison with serum activities and correlation to tumor staging and grading.
Carcinoma
Autocrine motility factor and its receptor expressions in human oral squamous cell carcinoma (SCC) cells.
Carcinoma
Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
Carcinoma
Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mapping.
Carcinoma
Clinical significance of serum lactate dehydrogenase, phosphohexose isomerase, aldolase and hexokinase in prostatic carcinoma.
Carcinoma
Combined use of serum enzyme levels as tumor markers in cervical carcinoma patients.
Carcinoma
Comparison of serum phosphohexose isomerase activity and urinary calcium excretion in a patient with metastatic mammary carcinoma.
Carcinoma
Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
Carcinoma
Diagnostic and prognostic significance of serum phosphohexose isomerase, aldolase and hexokinase in carcinoma cervix.
Carcinoma
Differential expression and pathological significance of autocrine motility factor/glucose-6-phosphate isomerase expression in human lung carcinomas.
Carcinoma
ENZYME STUDIES IN CEREBRAL TUMOURS. LACTATE DEHYDROGENASE, GLUCOSE PHOSPHATE ISOMERASE, ACID AND ALKALINE PHOSPHATASE IN PLASMA, VENTRICULAR CEREBROSPINAL FLUID AND TUMOUR CYST FLUID FROM CASES OF GLIOMA AND CEREBRAL SECONDARY CARCINOMA.
Carcinoma
Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma.
Carcinoma
Improved prognosis assessment for patients with bladder carcinoma.
Carcinoma
Increased Expression of the Autocrine Motility Factor is Associated With Poor Prognosis in Patients With Clear Cell-Renal Cell Carcinoma.
Carcinoma
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Carcinoma
Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.
Carcinoma
Possible use of phosphohexose isomerase as a preliminary to exfoliative cytology in screening for cervical carcinoma.
Carcinoma
Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin.
Carcinoma
Serum enzymes in patients with carcinoma of lung: lactic-acid dehydrogenase, phosphohexose isomerase, alkaline phosphatase and glutamic oxaloacetic transaminase.
Carcinoma
Serum phosphohexose isomerase in cancer. III. As an index of tumor growth in metastatic carcinoma of the prostate.
Carcinoma
Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast.
Carcinoma
Significance of serum phosphohexose isomerase, hexokinase and aldolase in carcinoma ovary.
Carcinoma
The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease.
Carcinoma
The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Carcinoma
Variants of phosphohexose isomerase in gastrointestinal and mammary carcinoma: isoelectric focusing patterns of normal and tumor tissues derived from surgical specimens of the same patient.
Carcinoma
[Detection of early tumor reactions in irradiation of tumors of the gastrointestinal tract by measuring the onco-radiogenic enzyme peak of glucosephosphate isomerase]
Carcinoma
[Possibilities for optimization of radiotherapy of esophageal carcinoma through measurement of the oncoradiogenic enzyme peak of glucosephosphate isomerase]
Carcinoma
[Possibilities for optimizing radiotherapy of cancers of the ENT area by measuring oncoradiogenic enzyme peaks of glucose-6-phosphate isomerase]
Carcinoma
[Quantitative studies of lysozyme and phosphohexose isomerase enzymes in mixed saliva in oral squamous epithelial carcinoma]
Carcinoma, Ehrlich Tumor
Glucose-6-phosphate isomerase from Ehrlich ascites tumor cells: purification and some properties.
Carcinoma, Hepatocellular
AMF/PGI transactivates the MMP-3 gene through the activation of Src-RhoA-phosphatidylinositol 3-kinase signaling to induce hepatoma cell migration.
Carcinoma, Hepatocellular
Autocrine motility factor enhances hepatoma cell invasion across the basement membrane through activation of beta1 integrins.
Carcinoma, Hepatocellular
Effect of Plumbagin on some glucose metabolising enzymes studied in rats in experimental hepatoma.
Carcinoma, Hepatocellular
Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Genetic variants in glucose-6-phosphate isomerase gene as prognosis predictors in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Human umbilical cord perivascular cells exhibited enhanced migration capacity towards hepatocellular carcinoma in comparison with bone marrow mesenchymal stromal cells: a role for autocrine motility factor receptor.
Carcinoma, Hepatocellular
Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.
Carcinoma, Hepatocellular
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Carcinoma, Hepatocellular
Modulating effect of Semecarpus anacardium Linn. nut extract on glucose metabolizing enzymes in aflatoxin B1-induced experimental hepatocellular carcinoma.
Carcinoma, Hepatocellular
Modulatory Role of Shorea robusta Bark on Glucose-metabolizing Enzymes in Diethylnitrosamine Induced Hepatocellular Carcinoma in Rats.
Carcinoma, Hepatocellular
Phosphohexose isomerase activity as a tumor marker in hepatoma bearing rats (Yoshida A.H. 130).
Carcinoma, Hepatocellular
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Carcinoma, Non-Small-Cell Lung
Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
Carcinoma, Renal Cell
Insulin-induced gene 1 (INSIG1) inhibits HIV-1 production by degrading Gag via activity of the ubiquitin ligase TRC8.
Carcinoma, Renal Cell
Phosphohexose isomerase in hypernephroma. Significance as serum tumor marker, comparison to other glycolytic enzymes and isozyme patterns in normal and tumor tissue.
Carcinoma, Squamous Cell
Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Carcinoma, Transitional Cell
Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
Carcinoma, Transitional Cell
Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
Cataract
[Variation of some enzymatic activities of the rat crystalline lens in experimental galactose cataract (lactate dehydrogenase, leucine aminopeptidase, phosphoglucose isomerase]
Cerebrovascular Disorders
[Effect of intravenous glucose load on blood glucose and fructose level and glucose-6-phosphate isomerase activity in serum of patients with acute cerebrovascular disease in its earliest phase]
Cholecystitis
[Blood serum phosphohexose isomerase in cholecystitis]
Cholestasis, Extrahepatic
Glucose phosphate isomerase and glutathione reductase in benign and malignant extrahepatic cholestasis.
Chordoma
The nature of cytoplasmic vacuoles in chordoma cells. A correlative enzyme and electron microscopic histochemical study.
Choriocarcinoma
Enzymes of normal and malignant trophoblast: phosphoglucose isomerase, phosphoglucomutase, hexokinase, lactate dehydrogenase, and alkaline phosphatase.
Choriocarcinoma
Expression and function of autocrine motility factor receptor in human choriocarcinoma.
Colitis, Ulcerative
Emerging views of mitophagy in immunity and autoimmune diseases.
Colonic Diseases
Quantitation and immunochemical characterization of carcinoembryonic antigen and glucose phosphate isomerase in blood and washings of patients with gastric and colonic diseases.
Colonic Neoplasms
Carcinoembryonic antigen and glucose phosphate isomerase in a human colonic cancer model (GW-39).
Colonic Neoplasms
The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin.
Colonic Neoplasms
Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase.
Colorectal Neoplasms
Enzymatic function of multiple origins regulates the progression of colorectal cancer and the development of metastases.
Colorectal Neoplasms
Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
Colorectal Neoplasms
Phosphoglucose isomerase enhances colorectal cancer metastasis.
Colorectal Neoplasms
Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
Colorectal Neoplasms
Serum phosphohexose isomerase activities in patients with colorectal cancer.
Congenital Abnormalities
Genetic and molecular mechanisms of the congenital defects in glucose phosphate isomerase activity: studies of four families.
Conjunctivitis
Genes for serum amyloid A proteins map to Chromosome 7 in the mouse.
Crohn Disease
Emerging views of mitophagy in immunity and autoimmune diseases.
Cysts
Cloning of two putative Giardia lamblia glucosamine 6-phosphate isomerase genes only one of which is transcriptionally activated during encystment.
Cysts
Cystic intracranial tumours. Cyst fluid, biochemical changes and computerised tomographic findings.
Cysts
ENZYME STUDIES IN CEREBRAL TUMOURS. LACTATE DEHYDROGENASE, GLUCOSE PHOSPHATE ISOMERASE, ACID AND ALKALINE PHOSPHATASE IN PLASMA, VENTRICULAR CEREBROSPINAL FLUID AND TUMOUR CYST FLUID FROM CASES OF GLIOMA AND CEREBRAL SECONDARY CARCINOMA.
Cysts
Variations in Echinococcus granulosus of bovine origin identified by enzyme electrophoresis.
Cysts
[Phosphohexose isomerase in cyst fluids and effusions as a complement to cytological diagnosis]
Dementia
Glycolytic enzymes from human autoptic brain cortex: normal aged and demented cases.
Dementia, Vascular
Codon 129 polymorphism specific cerebrospinal fluid proteome pattern in sporadic creutzfeldt-jakob disease and the implication of glycolytic enzymes in prion-induced pathology.
Diabetes Mellitus
Activation of hexokinase by mild insulin dependent diabetes mellitus in rat erythrocytes.
Diabetes Mellitus
Are syntax errors due to the amino acid sequence of neuroleukin involved in the pathogenesis of the acquired immunodeficiency syndrome (AIDS) and insulin dependent diabetes mellitus (IDDM)?
Diphtheria
Regulatory T cells control epitope spreading in autoimmune arthritis independent of cytotoxic T-lymphocyte antigen-4.
Dysentery
The zymodemes of Entamoeba histolytica in New Delhi, India.
Echinococcosis
Partial purification and properties of ovine liver Echinococcus granulosus protoscolices phospholgucose isomerase.
Endometrial Neoplasms
AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
Endometrial Neoplasms
Autocrine motility factor promotes endometrial cancer progression by targeting GPER-1.
Endometrial Neoplasms
Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
Endometrial Neoplasms
Enzymes of glucose metabolism in carcinoma of the cervix and endometrium of the human uterus.
Endometrial Neoplasms
POLE mutations improve the prognosis of endometrial cancer via regulating cellular metabolism through AMF/AMFR signal transduction.
Endometrial Neoplasms
Therapeutic potential of riboflavin, niacin and ascorbic Acid on carbohydrate metabolizing enzymes in secondary endometrial carcinoma bearing rats.
Esophageal Squamous Cell Carcinoma
Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma.
Fatty Liver
Secreted phosphoglucose isomerase is a novel biomarker of nonalcoholic fatty liver in mice and humans.
Fibrosarcoma
Differential purification of autocrine motility factor derived from a murine protein-free fibrosarcoma.
Fibrosarcoma
Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence.
Fibrosarcoma
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Fibrosarcoma
Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis.
Fibrosarcoma
Production of a motility factor by a newly established lung adenocarcinoma cell line.
Fibrosarcoma
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.
Fibrosarcoma
Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis.
Fructose Intolerance
Inhibition of glucose phosphate isomerase by metabolic intermediates of fructose.
Fructose Intolerance
[Influence of ACTH on some aspects of hydrocarbonate metabolism. II. Development of glycemia, fructosemia and phosphohexose isomerase (IFH) in adrenalectomized and normal rats]
Gastrointestinal Neoplasms
Multivariate analyses as aids to diagnosis and assessment of prognosis in gastrointestinal cancer.
Gastrointestinal Neoplasms
Significance of serum phosphohexose isomerase in gastrointestinal cancer at different stages.
Gastrointestinal Neoplasms
[Combination of cancer markers in the detection and prognosis of digestive system tumors]
Genetic Diseases, Inborn
Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation.
Genetic Diseases, Inborn
Glucose Phosphate Isomerase Deficiency: High Prevalence of p.Arg347His Mutation in Indian Population Associated with Severe Hereditary Non-Spherocytic Hemolytic Anemia Coupled with Neurological Dysfunction.
Genetic Diseases, Inborn
Molecular basis of neurological dysfunction coupled with haemolytic anaemia in human glucose-6-phosphate isomerase (GPI) deficiency.
Genetic Diseases, Inborn
Molecular diagnosis of unexplained haemolytic anaemia using targeted next-generation sequencing panel revealed (p.Ala337Thr) novel mutation in GPI gene in two Indian patients.
Genetic Diseases, Inborn
Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin.
Glioblastoma
Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population.
Glioblastoma
Silencing of phosphoglucose isomerase/autocrine motility factor decreases U87 human glioblastoma cell migration.
Glioblastoma
The secreted glycolytic enzyme GPI/AMF stimulates glioblastoma cell migration and invasion in an autocrine fashion but can have anti-proliferative effects.
Glioma
ENZYME STUDIES IN CEREBRAL TUMOURS. LACTATE DEHYDROGENASE, GLUCOSE PHOSPHATE ISOMERASE, ACID AND ALKALINE PHOSPHATASE IN PLASMA, VENTRICULAR CEREBROSPINAL FLUID AND TUMOUR CYST FLUID FROM CASES OF GLIOMA AND CEREBRAL SECONDARY CARCINOMA.
Glioma
Inhibition of IRE1 modifies hypoxic regulation of G6PD, GPI, TKT, TALDO1, PGLS and RPIA genes expression in U87 glioma cells.
Glioma
Neuroleukin secretion is highly regulated in T cells but constitutive in C6 glioma cells.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
A combined system for the study of glutathione metabolism in erythrocytes.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Combined erythrocyte phosphohexose isomerase and glucose-6-phosphate dehydrogenase deficiency.
glucose-6-phosphate dehydrogenase (nadp+) deficiency
Combined glucose phosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of erythrocytes.
glucose-6-phosphate isomerase deficiency
A combined system for the study of glutathione metabolism in erythrocytes.
glucose-6-phosphate isomerase deficiency
A new variant of glucosephosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Attenuation of Hemolysis Due to Glucose-6-Phosphate Isomerase Deficiency With Ketogenic Diet - A Case Report.
glucose-6-phosphate isomerase deficiency
Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases.
glucose-6-phosphate isomerase deficiency
Congenital haemolytic anaemia resulting from glucose phosphate isomerase deficiency: genetics, clinical picture, and prenatal diagnosis.
glucose-6-phosphate isomerase deficiency
Congenital Hemolytic Anemia Because of Glucose Phosphate Isomerase Deficiency: Identification of 2 Novel Missense Mutations in the GPI Gene.
glucose-6-phosphate isomerase deficiency
Detection of phosphohexose isomerase deficiency in human fibroblast cultures.
glucose-6-phosphate isomerase deficiency
DNA sequence abnormalities in human glucose 6-phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
glucose-6-phosphate isomerase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
glucose-6-phosphate isomerase deficiency
Erythrocyte pyruvate kinase- and glucose phosphate isomerase deficiency: perturbation of glycolysis by structural defects and functional alterations of defective enzymes and its relation to the clinical severity of chronic hemolytic anemia.
glucose-6-phosphate isomerase deficiency
First trimester monitoring of a pregnancy at risk for glucose phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase (GPI) Tadikonda: Characterization of a novel Pro340Ser mutation.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency as a cause of hydrops fetalis.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: a new variant (type Nordhorn). I. Clinical and genetic studies.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia: a new variant (type Nordhorn). II. Purification and biochemical properties of the defective enzyme.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency with hereditary hemolytic anemia in a Spanish family: clinical and familial studies.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency with hereditary nonspherocytic hemolytic anemia.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency. Unusual acute hemolytic crisis in a middle-aged woman.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency: biochemical and molecular genetic studies on the enzyme variants of two patients with severe haemolytic anaemia.
glucose-6-phosphate isomerase deficiency
Glucose phosphate isomerase deficiency: enzymatic and familial characterization of Arg346His mutation.
glucose-6-phosphate isomerase deficiency
Glucose Phosphate Isomerase Deficiency: High Prevalence of p.Arg347His Mutation in Indian Population Associated with Severe Hereditary Non-Spherocytic Hemolytic Anemia Coupled with Neurological Dysfunction.
glucose-6-phosphate isomerase deficiency
Glucose-6-phosphate isomerase deficiency associated with nonspherocytic hemolytic anemia in the mouse: an animal model for the human disease.
glucose-6-phosphate isomerase deficiency
Glucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1? to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic disease.
glucose-6-phosphate isomerase deficiency
Glucose-6-phosphate isomerase deficiency-Nahariya: extreme in vitro and in vivo lability of the mutant enzyme.
glucose-6-phosphate isomerase deficiency
Glucose-6-phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Haematological studies in a new variant of glucosephosphate isomerase deficiency (GPI Utrecht).
glucose-6-phosphate isomerase deficiency
Hematologically important mutations: molecular abnormalities of glucose phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Hemodialysis and kidney transplantation in a patient with glucose phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Hereditary non-spherocytic hemolytic anemia and severe glucose phosphate isomerase deficiency in an Indian patient homozygous for the L487F mutation in the human GPI gene.
glucose-6-phosphate isomerase deficiency
Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases.
glucose-6-phosphate isomerase deficiency
Molecular analysis of glucose phosphate isomerase deficiency associated with hereditary hemolytic anemia.
glucose-6-phosphate isomerase deficiency
Molecular characterization of glucose-6-phosphate isomerase deficiency in a mammalian cell mutant.
glucose-6-phosphate isomerase deficiency
Priapism caused by glucose phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Red blood cell disorders in Rwandese neonates: screening for sickle cell disease and glucose-6-phosphate dehydrogenase deficiency.
glucose-6-phosphate isomerase deficiency
Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
glucose-6-phosphate isomerase deficiency
Successful long-term phenobarbital therapy of hyperbilirubinemia in congenital hemolytic anemia due to glucose phosphate isomerase deficiency.
glucose-6-phosphate isomerase deficiency
Successful treatment of fetal hemolytic disease due to glucose phosphate isomerase deficiency (GPI) using repeated intrauterine transfusions: a case report.
glucose-6-phosphate isomerase deficiency
The characterization of gene mutations for human glucose phosphate isomerase deficiency associated with chronic hemolytic anemia.
glucose-6-phosphate isomerase deficiency
Two novel mutations (p.(Ser160Pro) and p.(Arg472Cys)) causing glucose-6-phosphate isomerase deficiency are associated with erythroid dysplasia and inappropriately suppressed hepcidin.
glucose-6-phosphate isomerase deficiency
[Glucose phosphate isomerase deficiency with congenital nonspherocytic hemolytic anemia]
glucose-6-phosphate isomerase deficiency
[Two cases in a family with new variants of glucose phosphate isomerase deficiency (author's transl)]
Glucosephosphate Dehydrogenase Deficiency
Combined erythrocyte phosphohexose isomerase and glucose-6-phosphate dehydrogenase deficiency.
Glucosephosphate Dehydrogenase Deficiency
Combined glucose phosphate isomerase and glucose-6-phosphate dehydrogenase deficiency of erythrocytes.
glutathione synthase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
glyceraldehyde-3-phosphate dehydrogenase (nad(p)+) (phosphorylating) deficiency
A simple screening procedure for glucose phosphate isomerase, phosphofructokinase, aldolase and glyceraldehyde-3-phosphate dehydrogenase deficiencies.
Graft vs Host Disease
Antibody-facilitated chimeras. Stem cell allotransplantation using antihost major histocompatibility complex monoclonal antibodies instead of lethal irradiation for host conditioning.
Head and Neck Neoplasms
Serum phosphohexose isomerase levels in patients with head and neck cancer.
Hematologic Diseases
[Behavior of phosphohexose isomerase activity (PHI) in the serum, pleural effusions, and ascitic fluids of subjects with malignant hematologic diseases and tumors]
Hepatitis
[Changes in the serum phosphohexose isomerase and leucine aminopeptidase levels during lysozyme treatment of viral hepatitis in childhood]
Hepatitis
[Serum phosphohexose isomerase in healthy children and those with viral hepatitis]
Hydrops Fetalis
Congenital haemolytic anaemia resulting from glucose phosphate isomerase deficiency: genetics, clinical picture, and prenatal diagnosis.
Hydrops Fetalis
Glucose phosphate isomerase (GPI) Tadikonda: Characterization of a novel Pro340Ser mutation.
Hydrops Fetalis
Glucose phosphate isomerase deficiency as a cause of hydrops fetalis.
Hypersensitivity
Glucose-6-phosphate isomerase deficiency results in mTOR activation, failed translocation of lipin 1? to the nucleus and hypersensitivity to glucose: Implications for the inherited glycolytic disease.
Hyperthyroidism
Adaptation of red cell enzymes and intermediates in metabolic disorders.
Hypoglycemia
Adaptation of red cell enzymes and intermediates in metabolic disorders.
Hypoglycemia
Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms.
Hypoxia, Brain
[Effect of hypoxia on carbohydrate metabolism in scorpion tissues]
Infections
Autoantigens and immune pathways in rheumatoid arthritis.
Infections
Differential expression of growth factors at the cellular level in virus-infected brain.
Infections
Electrophoretic variants of enzymes in isolates of Plasmodium falciparum, P. malariae and P. vivax from Thailand.
Infections
The effects of Minchinia nelsoni infection on enzyme levels in Crassostrea virginica. II. Serum phosphohexose isomerase.
Infections
Trypanosoma brucei infection induces apoptosis and up-regulates neuroleukin expression in the cerebellum.
Inflammatory Bowel Diseases
Emerging views of mitophagy in immunity and autoimmune diseases.
Intestinal Diseases
Serum phosphohexose isomerase activities in patients with colorectal cancer.
Kidney Neoplasms
Serum protein profiles in carcinoma of the kidney.
Kidney Neoplasms
Tumor collagenase-stimulating factor and tumor autocrine motility factor as tumor markers in bladder cancer--an update.
Leukemia
Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.
Leukemia
Down-regulation of Phosphoglucose Isomerase/Autocrine Motility Factor Enhances Gensenoside Rh2 Pharmacological Action on Leukemia KG1? Cells.
Leukemia
Neuroleukin mediated differentiation induction of myelogenous leukemia cells.
Leukemia
Plasma and intracellular levels of lactate dehydrogenase, phosphohexose isomerase and lysozyme activity in acute leukemia.
Leukemia
Plasma lactic dehydrogenase and phosphohexose isomerase in leukemia.
Leukemia
Studies on glycolytic enzymes in relation to cancer. I. Serum phosphohexose isomerase and aldolase in leukemia.
Leukemia
[ACTIVITY OF SERUM PHOSPHOHEXOSE ISOMERASE IN LEUKEMIA.]
Leukemia, Lymphocytic, Chronic, B-Cell
The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
Leukemia, Monocytic, Acute
Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Plasma and intracellular levels of lactate dehydrogenase, phosphohexose isomerase and lysozyme activity in acute leukemia.
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Puncta intended: connecting the dots between autophagy and cell stress networks.
Leukemia, Myeloid
A novel binding of GTP stabilizes the structure and modulates the activities of human phosphoglucose isomerase/autocrine motility factor.
Leukemia, Myeloid
Neuroleukin mediated differentiation induction of myelogenous leukemia cells.
Leukemia, Myeloid
The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase.
Leukemia, Myeloid, Acute
Human leukocyte glucose-phosphate-isomerase purification by affinity elution and immunological study.
Leukemia, Myeloid, Acute
Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases.
Leukemia, Myeloid, Acute
Plasma and intracellular levels of lactate dehydrogenase, phosphohexose isomerase and lysozyme activity in acute leukemia.
Liver Cirrhosis, Biliary
Emerging views of mitophagy in immunity and autoimmune diseases.
Liver Diseases
Diagnostic value of activity of malic dehydrogenase and phosphohexose isomerase; preliminary report of findings in patients with myocardial infarction and liver disease.
Liver Neoplasms
The effect of autocrine motility factor alone and in combination with methyl jasmonate on liver cancer cell growth.
Lung Neoplasms
Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
Lung Neoplasms
Autocrine motility factor receptor gene expression and cell motility in lung cancer cell lines.
Lung Neoplasms
Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
Lung Neoplasms
Effect of capsaicin on glucose metabolism studied in experimental lung carcinogenesis.
Lung Neoplasms
Phosphohexose isomerase and carcinoembryonic antigen in the sera of patients with primary lung cancer.
Lung Neoplasms
Phosphohexose isomerase in lung cancer.
Lung Neoplasms
Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Lung Neoplasms
The value of tumour markers in lung cancer.
Lung Neoplasms
[Value of serum phosphohexose isomerase in the diagnosis and prognosis of lung cancer]
Lupus Erythematosus, Systemic
Emerging views of mitophagy in immunity and autoimmune diseases.
Lymphatic Metastasis
Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
Lymphoma
Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma.
Lymphoma
Quantitative immunoassay of recombinant murine neuroleukin.
Lymphoma, Non-Hodgkin
Intracellular lactic dehydrogenase and phosphohexose isomerase activity in leukaemia and malignant lymphoma.
Lymphopenia
Arthritogenic self-reactive CD4+ T cells acquire an FR4hiCD73hi anergic state in the presence of Foxp3+ regulatory T cells.
Machado-Joseph Disease
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Malaria
Studies on enzyme variation in the murine malaria parasites Plasmodium berghei, P. yoelii, P. vinckei and P. chabaudi by starch gel electrophoresis.
Malnutrition
The metabolic flow rate through the phosphopyruvate hydratase and glucose phosphate isomerase steps of glycolysis in normal rat liver, in cirrhosis, and in quantitative undernutrition.
Melanoma
Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization.
Melanoma
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Melanoma
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Melanoma
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Melanoma
Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.
Melanoma
Autotaxin is an N-linked glycoprotein but the sugar moieties are not needed for its stimulation of cellular motility.
Melanoma
Both plasma lysophosphatidic acid and serum autotaxin levels are increased in chronic hepatitis C.
Melanoma
Carba analogs of cyclic phosphatidic acid are selective inhibitors of autotaxin and cancer cell invasion and metastasis.
Melanoma
Emerging views of mitophagy in immunity and autoimmune diseases.
Melanoma
Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
Melanoma
Heterogeneity of the motility responses in malignant tumor cells: a biological basis for the diversity and homing of metastatic cells.
Melanoma
Identification and characterization of autocrine-motility-factor-like activity in oral squamous-cell-carcinoma cells.
Melanoma
Pertussis toxin inhibits stimulated motility independently of the adenylate cyclase pathway in human melanoma cells.
Melanoma
Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
Melanoma
Production of a motility factor by a newly established lung adenocarcinoma cell line.
Melanoma
Purification of B16-F1 melanoma autocrine motility factor and its receptor.
Melanoma
Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Melanoma
Serum Autotaxin is not a Useful Biomarker for Ovarian Cancer.
Melanoma
Synthesis of novel 2-pyrrolidinone and pyrrolidine derivatives and study of their inhibitory activity against autotaxin enzyme.
Melanoma
[Significance of serum autotaxin activity in gastrointestinal disease]
Meningitis
Clinical significance and source of raised catalytic activities of phosphohexose isomerase in the CSF in meningitis.
Meningitis
Phosphohexose isomerase activity of cerebrospinal fluid. Activity in bacterial meningitis and other neurological diseases.
Meningitis
Phosphohexose isomerase in cerebrospinal fluid in meningitis.
Meningitis
[Significance of lactate level, lysozyme concentration and phosphohexose isomerase activity in the cerebrospinal fluid in the differential diagnosis of meningitis]
Meningitis, Bacterial
Clinical significance and source of raised catalytic activities of phosphohexose isomerase in the CSF in meningitis.
Meningitis, Bacterial
Phosphohexose isomerase activity of cerebrospinal fluid. Activity in bacterial meningitis and other neurological diseases.
Meningitis, Viral
Clinical significance and source of raised catalytic activities of phosphohexose isomerase in the CSF in meningitis.
Meningitis, Viral
Phosphohexose isomerase in cerebrospinal fluid in meningitis.
Multiple Myeloma
Amplification of autocrine motility factor and its receptor in multiple myeloma and other musculoskeletal tumors.
Myocardial Infarction
Diagnostic value of activity of malic dehydrogenase and phosphohexose isomerase; preliminary report of findings in patients with myocardial infarction and liver disease.
Myocardial Infarction
[Serum phosphohexose isomerase in the diagnosis of myocardial infarct]
Myocardial Infarction
[Value of phosphohexose isomerase (PHI) determination in myocardial infarct]
Myoclonic Epilepsies, Progressive
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Neoplasm Metastasis
Aberrant expression of the autocrine motility factor receptor correlates with poor prognosis and promotes metastasis in gastric carcinoma.
Neoplasm Metastasis
Activation of small GTPase Rho is required for autocrine motility factor signaling.
Neoplasm Metastasis
Association between autocrine motility factor receptor gene polymorphism (rs2440472, rs373191257) and glioblastoma multiform in a representative Iranian population.
Neoplasm Metastasis
Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Neoplasm Metastasis
Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization.
Neoplasm Metastasis
Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells.
Neoplasm Metastasis
Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Neoplasm Metastasis
Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Neoplasm Metastasis
Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression.
Neoplasm Metastasis
Calibration of the dianionic phosphate group: Validation on the recognition site of the homodimeric enzyme phosphoglucose isomerase.
Neoplasm Metastasis
Carbohydrate-based electrochemical biosensor for detection of a cancer biomarker in human plasma.
Neoplasm Metastasis
Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases.
Neoplasm Metastasis
Cell motility, a principal requirement for metastasis.
Neoplasm Metastasis
Crystal structures of mouse autocrine motility factor in complex with carbohydrate phosphate inhibitors provide insight into structure-activity relationship of the inhibitors.
Neoplasm Metastasis
Crystallization and preliminary X-ray crystallographic studies of mouse autocrine motility factor.
Neoplasm Metastasis
Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Neoplasm Metastasis
Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence.
Neoplasm Metastasis
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Neoplasm Metastasis
Elevated expression of autocrine motility factor receptor correlates with overexpression of RhoC and indicates poor prognosis in hepatocellular carcinoma.
Neoplasm Metastasis
Evaluation of phosphohexose isomerase as a metastasis marker in breast cancer patients.
Neoplasm Metastasis
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
Neoplasm Metastasis
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
Neoplasm Metastasis
Expression of autocrine motility factor receptor in colorectal cancer as a predictor for disease recurrence.
Neoplasm Metastasis
Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma.
Neoplasm Metastasis
Expression of autocrine motility factor receptor in serum- and protein-independent fibrosarcoma cells: implications for autonomy in tumor-cell motility and metastasis.
Neoplasm Metastasis
GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling.
Neoplasm Metastasis
Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.
Neoplasm Metastasis
Identification of metastasis-associated genes by transcriptional profiling of a pair of metastatic versus non-metastatic human mammary carcinoma cell lines.
Neoplasm Metastasis
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Neoplasm Metastasis
Inhibition mechanism of cytokine activity of human autocrine motility factor examined by crystal structure analyses and site-directed mutagenesis studies.
Neoplasm Metastasis
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Neoplasm Metastasis
Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.
Neoplasm Metastasis
Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies.
Neoplasm Metastasis
Overexpression of autocrine motility factor receptor (AMFR) in NIH3T3 fibroblasts induces cell transformation.
Neoplasm Metastasis
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Neoplasm Metastasis
Phosphoglucose isomerase enhances colorectal cancer metastasis.
Neoplasm Metastasis
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Neoplasm Metastasis
Phosphoglucose Isomerase/Autocrine Motility Factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Neoplasm Metastasis
Prognostic significance of autocrine motility factor receptor expression by colorectal cancer and lymph node metastases.
Neoplasm Metastasis
Pulmonary metastatic lesion of endolymphatic stromal myosis expresses metastasis-related genes but not invasion-related matrix type metalloproteinase.
Neoplasm Metastasis
Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis.
Neoplasm Metastasis
Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Neoplasm Metastasis
Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Neoplasm Metastasis
Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Neoplasm Metastasis
Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Neoplasm Metastasis
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Neoplasm Metastasis
Research models and mesenchymal/epithelial plasticity of osteosarcoma.
Neoplasm Metastasis
Serum protein profiles in carcinoma of the kidney.
Neoplasm Metastasis
Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Neoplasm Metastasis
Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis.
Neoplasm Metastasis
Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Neoplasm Metastasis
Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Neoplasm Metastasis
Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells.
Neoplasm Metastasis
The autocrine motility factor receptor gene encodes a novel type of seven transmembrane protein.
Neoplasm Metastasis
The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Neoplasm Metastasis
The role of autocrine motility factor in tumor and tumor microenvironment.
Neoplasm Metastasis
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.
Neoplasm Metastasis
Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Neoplasm Metastasis
Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Neoplasm Metastasis
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Neoplasm Metastasis
Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.
Neoplasm Metastasis
[Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm]
Neoplasm Metastasis
[Principles of tumor invasion and metastasis]
Neoplasm Metastasis
[Significance of serum autotaxin activity in gastrointestinal disease]
Neoplasm Metastasis
[The role of autocrine motility factor receptor in metastasis]
Neoplasms
6-phosphogluconate dehydrogenase, glucose-6-phosphate dehydrogenase, glucose-6-phosphate isomerase, and hexokinase activity ratios in some human tumor cytosols.
Neoplasms
A comparison of three blood tests for cancer.
Neoplasms
A lipoxygenase metabolite, 12-(S)-HETE, stimulates protein kinase C-mediated release of cathepsin B from malignant cells.
Neoplasms
A new method for evaluation of urinary autocrine motility factor and tumor cell collagenase stimulating factor as markers for urinary tract cancers.
Neoplasms
Activation of small GTPase Rho is required for autocrine motility factor signaling.
Neoplasms
Activities of phosphohexose isomerase and other glycolytic enzymes in normal and tumor tissue of patients with neoplastic diseases: comparison with serum activities and correlation to tumor staging and grading.
Neoplasms
AMF/PGI-mediated tumorigenesis through MAPK-ERK signaling in endometrial carcinoma.
Neoplasms
Amplification of autocrine motility factor and its receptor in multiple myeloma and other musculoskeletal tumors.
Neoplasms
An autocrine motility factor secreted by the Dunning R-3327 rat prostatic adenocarcinoma cell subtype AT2.1.
Neoplasms
Antibody responses associated with the graft-versus-leukemia effect in adult T-cell leukemia.
Neoplasms
Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
Neoplasms
Autocrine motility factor (neuroleukin, phosphohexose isomerase) induces cell movement through 12-lipoxygenase-dependent tyrosine phosphorylation and serine dephosphorylation events.
Neoplasms
Autocrine motility factor and its receptor expression in musculoskeletal tumors.
Neoplasms
Autocrine motility factor and its receptor expressions in human oral squamous cell carcinoma (SCC) cells.
Neoplasms
Autocrine motility factor and its receptor: role in cell locomotion and metastasis.
Neoplasms
Autocrine motility factor and the extracellular matrix. I. Coordinate regulation of melanoma cell adhesion, spreading and migration involves focal contact reorganization.
Neoplasms
Autocrine motility factor and the extracellular matrix. II. Degradation or remodeling of substratum components directs the motile response of tumor cells.
Neoplasms
Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high- and low-metastatic K1735 melanoma cell variants.
Neoplasms
Autocrine motility factor is a growth factor.
Neoplasms
Autocrine Motility Factor Modulates EGF-Mediated Invasion Signaling.
Neoplasms
Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
Neoplasms
Autocrine motility factor receptor as a possible urine marker for transitional cell carcinoma of the bladder.
Neoplasms
Autocrine motility factor receptor expression associates with tumor progression in thymoma.
Neoplasms
Autocrine motility factor receptor expression in patients with stage I non-small cell lung cancer.
Neoplasms
Autocrine motility factor receptor is a marker for a distinct membranous tubular organelle.
Neoplasms
Autocrine motility factor receptor promotes the proliferation of human acute monocytic leukemia THP-1 cells.
Neoplasms
Autocrine Motility Factor Receptor Signaling Pathway Promotes Cell Invasion via Activation of ROCK-2 in Esophageal Squamous Cell Cancer Cells.
Neoplasms
Autocrine motility factor secreted by HeLa cells inhibits the growth of many cancer cells by regulating AKT/ERK signaling.
Neoplasms
Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt-1) expression in endothelial cells.
Neoplasms
Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Neoplasms
Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression.
Neoplasms
Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion.
Neoplasms
Autocrine motility factor stimulates a three-fold increase in inositol trisphosphate in human melanoma cells.
Neoplasms
Autocrine motility factor stimulates the invasiveness of malignant cells as well as up-regulation of matrix metalloproteinase-3 expression via a MAPK pathway.
Neoplasms
Autocrine motility factor-receptor gene expression in lung cancer.
Neoplasms
Autocrine motility factor/glucose-6-phosphate isomerase is a possible predictor of metastasis in bone and soft tissue tumours.
Neoplasms
Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release.
Neoplasms
Betulinic Acid Exerts Cytotoxic Activity Against Multidrug-Resistant Tumor Cells via Targeting Autocrine Motility Factor Receptor (AMFR).
Neoplasms
Biochemical markers in ovarian cancer: possibilities and limitations.
Neoplasms
Biochemical mechanisms of tumor invasion and metastases.
Neoplasms
Biochemical mechanisms of tumor invasion and metastasis.
Neoplasms
Biological characteristics of carcinomatosa pleuritis in orthotopic model systems using immune-deficient rats.
Neoplasms
Calibration of the dianionic phosphate group: Validation on the recognition site of the homodimeric enzyme phosphoglucose isomerase.
Neoplasms
Carbohydrate-based electrochemical biosensor for detection of a cancer biomarker in human plasma.
Neoplasms
Carbon Source Affects Synthesis, Structures, and Activities of Mycelial Polysaccharides from Medicinal Fungus Inonotus obliquus.
Neoplasms
Carcinoembryonic antigen and glucose phosphate isomerase in a human colonic cancer model (GW-39).
Neoplasms
Carcinoembryonic antigen and phosphohexose isomerase, gammaglutamyl transpeptidase and lactate dehydorgenase levels in patients with and without liver metastases.
Neoplasms
Cell motility, a principal requirement for metastasis.
Neoplasms
Comparison of phosphohexose isomerase and lactic dehydrogenase activities in plasma, liver, and tumor tissue of tumor-bearing rats.
Neoplasms
CYP3A4 ubiquitination by gp78 (the tumor autocrine motility factor receptor, AMFR) and CHIP E3 ligases.
Neoplasms
Cytokine-induced pseudopodial protrusion is coupled to tumour cell migration.
Neoplasms
Cytoskeletal agents inhibit motility and adherence of human tumor cells.
Neoplasms
Design, synthesis, and anticancer activity evaluation of irreversible allosteric inhibitors of the ubiquitin-conjugating enzyme Ube2g2.
Neoplasms
Detection of autocrine motility factor in urine as a marker of bladder cancer.
Neoplasms
Differential regulation of phosphoglucose isomerase/autocrine motility factor activities by protein kinase CK2 phosphorylation.
Neoplasms
Disrupting glucose-6-phosphate isomerase fully suppresses the "Warburg effect" and activates OXPHOS with minimal impact on tumor growth except in hypoxia.
Neoplasms
Distribution of tumor-sensitized cells during the induction of permanent tumor regression by chemoimmunotherapy: the use of glucose phosphate isomerase as a marker.
Neoplasms
Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence.
Neoplasms
Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells.
Neoplasms
Efficacy of Terminalia arjuna (Roxb.) on N-nitrosodiethylamine induced hepatocellular carcinoma in rats.
Neoplasms
Emerging views of mitophagy in immunity and autoimmune diseases.
Neoplasms
ENZYME STUDIES IN CEREBRAL TUMOURS. LACTATE DEHYDROGENASE, GLUCOSE PHOSPHATE ISOMERASE, ACID AND ALKALINE PHOSPHATASE IN PLASMA, VENTRICULAR CEREBROSPINAL FLUID AND TUMOUR CYST FLUID FROM CASES OF GLIOMA AND CEREBRAL SECONDARY CARCINOMA.
Neoplasms
Enzymes of glucose metabolism in carcinoma of the cervix and endometrium of the human uterus.
Neoplasms
Evodiamine Induces Apoptosis and Inhibits Migration of HCT-116 Human Colorectal Cancer Cells.
Neoplasms
Expression and function of autocrine motility factor receptor in human choriocarcinoma.
Neoplasms
Expression and secretion of neuroleukin/phosphohexose isomerase/maturation factor as autocrine motility factor by tumor cells.
Neoplasms
Expression of Autocrine Motility Factor (AMF) and Its Receptor, AMFR, in Human Breast Cancer.
Neoplasms
Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer.
Neoplasms
Expression of autocrine motility factor mRNA is a poor prognostic factor in high-grade astrocytoma.
Neoplasms
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
Neoplasms
Expression of autocrine motility factor receptor in cutaneous malignant melanoma.
Neoplasms
Expression of autocrine motility factor receptor in human esophageal squamous cell carcinoma.
Neoplasms
Expression of autocrine motility factor/phosphohexose isomerase in Cos7 cells.
Neoplasms
Expression of the AMF/neuroleukin receptor in developing and adult brain cerebellum.
Neoplasms
Extragonadal teratocarcinoma derived from embryonal stem cells in chimaeric mice.
Neoplasms
Gastric Schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: Report of two cases.
Neoplasms
Glucose metabolic analysis of musculoskeletal tumours using 18fluorine-FDG PET as an aid to preoperative planning.
Neoplasms
Glucose-6-phosphate isomerase from Ehrlich ascites tumor cells: purification and some properties.
Neoplasms
GP78 Cooperates with Dual-Specificity Phosphatase 1 To Stimulate Epidermal Growth Factor Receptor-Mediated Extracellular Signal-Regulated Kinase Signaling.
Neoplasms
Heregulin regulation of autocrine motility factor expression in human tumor cells.
Neoplasms
Higher autocrine motility factor/glucose-6-phosphate isomerase expression is associated with tumorigenesis and poorer prognosis in gastric cancer.
Neoplasms
Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.
Neoplasms
Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells.
Neoplasms
Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours.
Neoplasms
Increased migration of human mesenchymal stromal cells by autocrine motility factor (AMF) resulted in enhanced recruitment towards hepatocellular carcinoma.
Neoplasms
Induction of hepatoma cells migration by phosphoglucose isomerase/autocrine motility factor through the upregulation of matrix metalloproteinase-3.
Neoplasms
Induction via Functional Protein Stabilization of Hepatic Cytochromes P450 upon gp78/Autocrine Motility Factor Receptor (AMFR) Ubiquitin E3-ligase Genetic Ablation in Mice: Therapeutic and Toxicological Relevance.
Neoplasms
Inhibition of Non-flux-Controlling Enzymes Deters Cancer Glycolysis by Accumulation of Regulatory Metabolites of Controlling Steps.
Neoplasms
Inverse relation of autocrine motility factor receptor and E-cadherin expression following MDCK epithelial cell transformation.
Neoplasms
Inverse relation of E-cadherin and autocrine motility factor receptor expression as a prognostic factor in patients with bladder carcinomas.
Neoplasms
Isozyme pattern in serially xenotransplanted childhood tumors.
Neoplasms
Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Neoplasms
Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases.
Neoplasms
Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway.
Neoplasms
Metabolic Plasiticy in Cancers-Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs.
Neoplasms
Molecular association of glucose-6-phosphate isomerase and pyruvate kinase M2 with glyceraldehyde-3-phosphate dehydrogenase in cancer cells.
Neoplasms
Monoclonal antibodies against autocrine motility factor suppress gastric cancer.
Neoplasms
More on phosphohexose isomerase as a tumor marker.
Neoplasms
Non-invasive imaging of tumors by monitoring autotaxin activity using an enzyme-activated near-infrared fluorogenic substrate.
Neoplasms
Novel N-substituted 5-phosphate-d-arabinonamide derivatives as strong inhibitors of phosphoglucose isomerases: Synthesis, structure-activity relationship and crystallographic studies.
Neoplasms
Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy.
Neoplasms
Overexpression of autocrine motility factor in metastatic tumor cells: possible association with augmented expression of KIF3A and GDI-beta.
Neoplasms
Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts.
Neoplasms
Overexpression of the tumor autocrine motility factor receptor Gp78, a ubiquitin protein ligase, results in increased ubiquitinylation and decreased secretion of apolipoprotein B100 in HepG2 cells.
Neoplasms
Pectic polysaccharide from corn (Zea mays L.) effectively inhibited multi-step mediated cancer cell growth and metastasis.
Neoplasms
Peripherally located occult lung cancer with AMFR expression.
Neoplasms
Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer.
Neoplasms
Phosphoglucose Isomerase/Autocrine Motility Factor mediates epithelial-mesenchymal transition regulated by miR-200 in breast cancer cells.
Neoplasms
Phosphoglucose isomerase/autocrine motility factor promotes melanoma cell migration through ERK activation dependent on autocrine production of interleukin-8.
Neoplasms
Phosphohexose isomerase activity as a tumor marker in hepatoma bearing rats (Yoshida A.H. 130).
Neoplasms
Phosphohexose isomerase in hypernephroma. Significance as serum tumor marker, comparison to other glycolytic enzymes and isozyme patterns in normal and tumor tissue.
Neoplasms
Phosphohexose isomerase/autocrine motility factor/neuroleukin/maturation factor is a multifunctional phosphoprotein.
Neoplasms
Phosphohexose isomerase: a useful parameter in the management of neoplasia.
Neoplasms
Potential endocrine function of the glycolytic enzyme glucose-6-phosphate isomerase during implantation.
Neoplasms
Preadipocyte stimulating factor in rat serum: evidence for a discrete 63 kDa protein that promotes cell differentiation of rat preadipocytes in primary cultures.
Neoplasms
Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.
Neoplasms
Protein factors which regulate cell motility.
Neoplasms
Purification and characterization of phosphohexose isomerase from human gastrointestinal carcinoma and its potential relationship to neuroleukin.
Neoplasms
Purification of B16-F1 melanoma autocrine motility factor and its receptor.
Neoplasms
Purification of human tumor cell autocrine motility factor and molecular cloning of its receptor.
Neoplasms
Raft endocytosis of AMF regulates mitochondrial dynamics through Rac1 signaling and the Gp78 ubiquitin ligase.
Neoplasms
Raft-dependent endocytosis of autocrine motility factor/phosphoglucose isomerase: a potential drug delivery route for tumor cells.
Neoplasms
Regulation and biological activities of the autotaxin-LPA axis.
Neoplasms
Regulation of autocrine motility factor receptor expression in tumor cell locomotion and metastasis.
Neoplasms
Regulation of cell motility via high and low affinity autocrine motility factor (AMF) receptor in human oral squamous carcinoma cells.
Neoplasms
Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Neoplasms
Regulation of melanoma-cell motility by the lipoxygenase metabolite 12-(S)-HETE.
Neoplasms
Regulation of phosphoglucose isomerase/autocrine motility factor activities by the poly(ADP-ribose) polymerase family-14.
Neoplasms
Regulation of phosphoglucose isomerase/autocrine motility factor expression by hypoxia.
Neoplasms
Release of glycolytic enzymes from cultivated tumor cells.
Neoplasms
RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer.
Neoplasms
Scatter factor and other regulators of cell mobility.
Neoplasms
Screening and X-ray Crystal Structure-based Optimization of Autotaxin (ENPP2) Inhibitors, Using a Newly Developed Fluorescence Probe.
Neoplasms
Serum phosphohexose isomerase in cancer.
Neoplasms
Serum phosphohexose isomerase in cancer. III. As an index of tumor growth in metastatic carcinoma of the prostate.
Neoplasms
Serum phosphohexose isomerase in cancer. I. Method of determination and establishment of range of normal values.
Neoplasms
Serum phosphohexose isomerase in cancer. II. As an index of tumor growth in metastatic carcinoma of the breast.
Neoplasms
Serum phosphohexose isomerase in cancer. IV. Comparison with serum-phosphoglucomutase activity in metastatic cancer.
Neoplasms
Serum protein profiles in carcinoma of the kidney.
Neoplasms
Serum Th1 and Th17 related cytokines and autoantibodies in patients with Posner-Schlossman syndrome.
Neoplasms
Significance of autocrine motility factor receptor gene expression as a prognostic factor in non-small-cell lung cancer.
Neoplasms
Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis.
Neoplasms
Strategies of chemoprevention based on antigenic and molecular markers of early and premalignant lesions of the bladder.
Neoplasms
Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Neoplasms
Studies on glycolytic enzymes in relation to cancer. I. Serum phosphohexose isomerase and aldolase in leukemia.
Neoplasms
Studies on glycolytic enzymes in relation to cancer. Part IV: Sera and effusion activities of phosphohexose isomerase, aldolase and lactic dehydrogenase in malignant and benign conditions.
Neoplasms
Study of serum phosphohexose isomerase (PHI) levels in the management of head and neck malignancies.
Neoplasms
Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model.
Neoplasms
Suppression of melanoma cell motility factor receptor expression by retinoic acid.
Neoplasms
Synergistic effects of autocrine motility factor and methyl jasmonate on human breast cancer cells.
Neoplasms
Synthesis and biological evaluation of phosphonate derivatives as autotaxin (ATX) inhibitors.
Neoplasms
The autocrine motility factor (AMF) and AMF-receptor combination needs sugar chain recognition ability and interaction using the C-terminal region of AMF.
Neoplasms
The cellular origin of chemically induced tumours.
Neoplasms
The complex biology of autocrine motility factor/phosphoglucose isomerase (AMF/PGI) and its receptor, the gp78/AMFR E3 ubiquitin ligase.
Neoplasms
The crystal structure of phosphoglucose isomerase/autocrine motility factor/neuroleukin complexed with its carbohydrate phosphate inhibitors suggests its substrate/receptor recognition.
Neoplasms
The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer.
Neoplasms
The effect of autocrine motility factor alone and in combination with methyl jasmonate on liver cancer cell growth.
Neoplasms
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance.
Neoplasms
The relation between the growth patterns of gastric carcinoma and the expression of hepatocyte growth factor receptor (c-met), autocrine motility factor receptor, and urokinase-type plasminogen activator receptor.
Neoplasms
The role of autocrine motility factor in tumor and tumor microenvironment.
Neoplasms
The role of autotaxin and other motility stimulating factors in the regulation of tumor cell motility.
Neoplasms
The tumor autocrine motility factor receptor, gp78, is a ubiquitin protein ligase implicated in degradation from the endoplasmic reticulum.
Neoplasms
The value of tumour markers in lung cancer.
Neoplasms
Therapeutic effect of tamoxifen and energy-modulating vitamins on carbohydrate-metabolizing enzymes in breast cancer.
Neoplasms
Therapeutic effects of antibodies to tumor necrosis factor-alpha, interleukin-6 and cytotoxic T-lymphocyte antigen 4 immunoglobulin in mice with glucose-6-phosphate isomerase induced arthritis.
Neoplasms
Therapeutic targeting of circ-CUX1/EWSR1/MAZ axis inhibits glycolysis and neuroblastoma progression.
Neoplasms
Tissue glycolytic enzymes in primary breast cancer patients receiving adjuvant chemotherapy.
Neoplasms
Tumor autocrine motility factor induces hyperpermeability of endothelial and mesothelial cells leading to accumulation of ascites fluid.
Neoplasms
Tumor autocrine motility factor is an angiogenic factor hat stimulates endothelial cell motility.
Neoplasms
Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility.
Neoplasms
Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells.
Neoplasms
Tumor autocrine motility factor.
Neoplasms
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptide.
Neoplasms
Tumor cell autocrine motility factor receptor.
Neoplasms
Tumor cell autocrine motility factor.
Neoplasms
Tumor cell motility and metastasis : Autocrine motility factor as an example of ecto/exoenzyme cytokines.
Neoplasms
Tumor collagenase stimulating factor (TCSF) and tumor autocrine motility factor (TAMF) in bladder cancer.
Neoplasms
Tumor collagenase-stimulating factor and tumor autocrine motility factor as tumor markers in bladder cancer--an update.
Neoplasms
Tumor enzymes and prognosis in transitional cell carcinoma of the bladder: prediction of risk of progression in patients with superficial disease.
Neoplasms
Tumor progression- and metastasis-associated proteins identified using a model of locally recurrent rat mammary adenocarcinomas.
Neoplasms
Up-regulation of Key Glycolysis Proteins in Cancer Development.
Neoplasms
Variants of phosphohexose isomerase in gastrointestinal and mammary carcinoma: isoelectric focusing patterns of normal and tumor tissues derived from surgical specimens of the same patient.
Neoplasms
Warburg effect increases steady-state ROS condition in cancer cells through decreasing their antioxidant capacities (Anticancer effects of 3-bromopyruvate through antagonizing Warburg effect).
Neoplasms
Who controls the ATP supply in cancer cells? Biochemistry lessons to understand cancer energy metabolism.
Neoplasms
Whole-transcriptome Analysis of Fully Viable Energy Efficient Glycolytic-null Cancer Cells Established by Double Genetic Knockout of Lactate Dehydrogenase A/B or Glucose-6-Phosphate Isomerase.
Neoplasms
[Behavior of malate dehydrogenase (MDH), FDP-aldolase (ALD) and phosphoglucose isomerase (PGI) in the serum of tumor patients during radiotherapy]
Neoplasms
[Behavior of phosphohexose isomerase activity (PHI) in the serum, pleural effusions, and ascitic fluids of subjects with malignant hematologic diseases and tumors]
Neoplasms
[Clinical significance of the determination of serum phosphohexose isomerase in malignant neoplasms]
Neoplasms
[CLINICAL STUDIES ON SERUM GLYCOLYTIC ENZYMES IN CANCER PATIENTS; ON PHOSPHOHEXOSE ISOMERASE, PHOSPHOGLUCOMUTASE AND LACTIC DEHYDROGENASE ACTIVITIES.]
Neoplasms
[Comparative evaluation of lactate dehydrogenase and glucose-6-phosphate isomerase activity in patients with neoplasms]
Neoplasms
[Determination of phosphohexose isomerase (PHI) as a diagnostic aid in the prognosis of malignant neoplasms.]
Neoplasms
[Enzymatic changes in cancer]
Neoplasms
[Possibilities for optimizing radiotherapy of cancers of the ENT area by measuring oncoradiogenic enzyme peaks of glucose-6-phosphate isomerase]
Neoplasms
[Possibility that AMF will serve as a target molecule for the diagnosis and treatment of a metastatic neoplasm]
Neoplasms
[Principles of tumor invasion and metastasis]
Neoplasms
[Progress in research on autocrine motility factor and its receptor in tumor biology].
Neoplasms
[Significance of serum autotaxin activity in gastrointestinal disease]
Neoplasms
[The activity of isocitra dehydrogenase and of phosphohexose isomerase in the serum of patientwith malignant tumors of the mouth cavity]
Neoplasms
[The determination of phosphohexose isomerase in patients with cancer of breast and uterus. A comparison with other tests (author's transl)]
Neoplasms
[The role of autocrine motility factor receptor in metastasis]
Neoplasms
[The value of urine phosphohexose isomerase activity in comparison with urine cytology. First diagnosis and tumor after-care in patients with cancer of the urinary bladder]
Neoplasms, Squamous Cell
Autocrine Motility Factor Receptor Signaling Pathway Promotes Cell Invasion via Activation of ROCK-2 in Esophageal Squamous Cell Cancer Cells.
Nervous System Diseases
Glucose Phosphate Isomerase Deficiency: High Prevalence of p.Arg347His Mutation in Indian Population Associated with Severe Hereditary Non-Spherocytic Hemolytic Anemia Coupled with Neurological Dysfunction.
Neuroblastoma
Effect of oxygen and glucose availability on the glycolytic rate in neuroblastoma cells under different conditions of culture.
Neuroblastoma
Neurotrophic activity of monomeric glucophosphoisomerase was blocked by human immunodeficiency virus (HIV-1) and peptides from HIV-1 envelope glycoprotein.
Non-alcoholic Fatty Liver Disease
Secreted phosphoglucose isomerase is a novel biomarker of nonalcoholic fatty liver in mice and humans.
Obesity
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle.
Odontogenic Tumors
Immunohistochemical expression of Type IV Collagen and Autocrine Motility Factor Receptor in Odontogenic Tumours.
Osteoarthritis
Detection of antibodies against glucose 6-phosphate isomerase in synovial fluid of rheumatoid arthritis using surface plasmon resonance (BIAcore).
Osteoarthritis, Knee
Elevated Serum Glucose-6-Phosphate Isomerase Level in Patients with Knee Osteoarthritis.
Osteosarcoma
Effects of protein kinase inhibitors on the cell motility stimulated by autocrine motility factor.
Osteosarcoma
Hyperthermia reduces migration of osteosarcoma by suppression of autocrine motility factor.
Osteosarcoma
Prognostic significance of 18F-FDG uptake in primary osteosarcoma after but not before chemotherapy: a possible association with autocrine motility factor/phosphoglucose isomerase expression.
Osteosarcoma
Silencing of Autocrine Motility Factor Induces Mesenchymal-to-Epithelial Transition and Suppression of Osteosarcoma Pulmonary Metastasis.
Ovarian Neoplasms
Down-regulation of Ras-related protein Rab 5C-dependent endocytosis and glycolysis in cisplatin-resistant ovarian cancer cell lines.
Ovarian Neoplasms
Microarray analysis of differentially expressed genes associated with human ovarian cancer.
Ovarian Neoplasms
Puncta intended: connecting the dots between autophagy and cell stress networks.
Pancreatic Neoplasms
Autocrine motility factor signaling enhances pancreatic cancer metastasis.
Pancreatic Neoplasms
Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells.
Papilloma
Autocrine motility factor-receptor in human bladder-carcinoma - gene-expression, loss of cell-contact regulation and chromosomal mapping.
Paramyxoviridae Infections
Emerging views of mitophagy in immunity and autoimmune diseases.
Parasitic Diseases
Parasites in Bulinus senegalensis (Mollusca: Planorbidae) and their detection.
Parkinsonian Disorders
Emerging views of mitophagy in immunity and autoimmune diseases.
phosphoglucomutase (alpha-d-glucose-1,6-bisphosphate-dependent) deficiency
Acquired erythroenzymopathies in blood disorders: study of 200 cases.
phosphoglycerate kinase deficiency
Enzymatic diagnosis in non-spherocytic hemolytic anemia.
Pleural Effusion
[Behavior of phosphohexose isomerase activity (PHI) in the serum, pleural effusions, and ascitic fluids of subjects with malignant hematologic diseases and tumors]
Pneumonia
[Phosphohexose isomerase and aldolase of the blood serum in pneumonia in children]
Poliomyelitis
Evidence for synteny between a polio receptor gene and glucose phosphate isomerase (GPI) by analysis of human-mouse hybrids.
Priapism
Priapism caused by glucose phosphate isomerase deficiency.
Prostatic Neoplasms
Loss of cell-contact regulation and altered responses to autocrine motility factor correlate with increased malignancy in prostate cancer cells.
Prostatic Neoplasms
Studies on glycolytic enzymes in relation to cancer. 3. Clinical significance of serum phosphohexose isomerase and aldolase in cancer of the prostate. A comparative study with serum acid phosphatase and serum alkaline phosphatase.
Psoriasis
[Phosphohexose isomerase in psoriasis]
Psoriasis
[Studies of the activity decrease of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. 3.]
Psoriasis
[Studies of the activity of glucose phosphate isomerase in thrombocytes and leukocytes of patients with florid psoriasis vulgaria]
Psoriasis
[Studies of the mechanism of the activity diminution of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. I]
Psoriasis
[Studies on the inhibiting factor of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris]
Psoriasis
[Studies on the mechanism of the activity decrease of phosphoglucose isomerase in erythrocytes of patients with florid psoriasis vulgaris. II]
pyruvate kinase deficiency
A combined system for the study of glutathione metabolism in erythrocytes.
pyruvate kinase deficiency
Next-Generation Sequencing-Based Diagnosis of Unexplained Inherited Hemolytic Anemias Reveals Wide Genetic and Phenotypic Heterogeneity.
pyruvate kinase deficiency
Study of pathophysiology and molecular characterization of congenital anemia in India using targeted next-generation sequencing approach.
Respiratory Insufficiency
Glycolytic enzymes of human fetal and neonatal intraocular fluids.
Retinitis Pigmentosa
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Retinoblastoma
Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling.
Sarcoma
Distribution of tumor-sensitized cells during the induction of permanent tumor regression by chemoimmunotherapy: the use of glucose phosphate isomerase as a marker.
Sarcoma
Sheep gene mapping: additional DNA markers included (CASB, CASK, LALBA, IGF-1 and AMH).
Sialadenitis
[Phosphohexose isomerase activity in parotid and submandibular saliva as a parameter in the diagnosis of chronic sialadenitis]
Skin Diseases
[Activity of serum phosphohexose isomerase in some skin diseases]
Spinocerebellar Ataxias
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Squamous Cell Carcinoma of Head and Neck
Autocrine motility factor and its receptor expressions in human oral squamous cell carcinoma (SCC) cells.
Starvation
Down-regulation of Sp1 activity through modulation of O-glycosylation by treatment with a low glucose mimetic, 2-deoxyglucose.
Stillbirth
Glycolytic enzymes of human fetal and neonatal intraocular fluids.
Stomach Neoplasms
Correlation between loss of E-cadherin expression and overexpression of autocrine motility factor receptor in association with progression of human gastric cancers.
Stomach Neoplasms
Expression of autocrine motility factor correlates with the angiogenic phenotype of and poor prognosis for human gastric cancer.
Stomach Neoplasms
Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer.
Stomach Neoplasms
Monoclonal antibodies against autocrine motility factor suppress gastric cancer.
Stomach Neoplasms
Phosphoglucose isomerase gene expression as a prognostic biomarker of gastric cancer.
Subarachnoid Hemorrhage
[The effect of intravenous glucose load on levels of glucose and fructose and activity of glucose-6-phosphate isomerase in serum of patients with subarachnoid hemorrhage]
Thymoma
Autocrine motility factor receptor expression associates with tumor progression in thymoma.
Thymoma
Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.
Thyroid Neoplasms
Expression of Gp78/Autocrine Motility Factor Receptor and Endocytosis of Autocrine Motility Factor in Human Thyroid Cancer Cells.
Tongue Neoplasms
[Optimizing radiotherapy for carcinomas of the tongue and floor of the mouth. Measurement of oncoradiogenic enzyme peaks of GPI]
Triple Negative Breast Neoplasms
Diverse mechanisms of autophagy dysregulation and their therapeutic implications: does the shoe fit?
Triple Negative Breast Neoplasms
Puncta intended: connecting the dots between autophagy and cell stress networks.
Tuberculosis
Biochemical characterization of recombinant phosphoglucose isomerase of Mycobacterium tuberculosis.
Tuberculosis
Crystallization and preliminary X-ray characterization of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv.
Tuberculosis
Establishment of an effective TLC bioautographic method for the detection of Mycobacterium tuberculosis H37Ra phosphoglucose isomerase inhibition by phosphoenolpyruvate.
Tuberculosis
Functional phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv: rapid purification with high yield and purity.
Tuberculosis
Structural studies of phosphoglucose isomerase from Mycobacterium tuberculosis H37Rv.
Urinary Bladder Neoplasms
Comparison of the nuclear matrix protein 22 with voided urine cytology in the diagnosis of transitional cell carcinoma of the bladder.
Urinary Bladder Neoplasms
Detection of autocrine motility factor in urine as a marker of bladder cancer.
Urinary Bladder Neoplasms
Tumor collagenase stimulating factor (TCSF) and tumor autocrine motility factor (TAMF) in bladder cancer.
Urologic Neoplasms
A new method for evaluation of urinary autocrine motility factor and tumor cell collagenase stimulating factor as markers for urinary tract cancers.
Vascular System Injuries
Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells.
Virus Diseases
Friend viral pathogenesis in C57BL/6 reversible DBA/2 allophenic mice.
Whooping Cough
Autocrine motility factor is a growth factor.
Whooping Cough
Autotaxin is an exoenzyme possessing 5'-nucleotide phosphodiesterase/ATP pyrophosphatase and ATPase activities.
Whooping Cough
Identification of B16-F1 melanoma autocrine motility-like factor receptor.
Whooping Cough
Insulin-like growth factors stimulate chemotaxis in human melanoma cells.
Whooping Cough
The type I insulin-like growth factor receptor is a motility receptor in human melanoma cells.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
5.3.1.9 glucose-6-phosphate isomerase
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
